A Phase I, Open-Label, Multidose, Dose-Escalation Trial of Fontolizumab to Explore Safety and Pharmacology in Patients with Moderate-to-Severe Crohns Disease

  • De Villiers, Willem (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date1/28/04 → 6/30/06